JWA
CVS icon

JFS Wealth Advisors’s CVS Health CVS Stock Holding History

JFS Wealth Advisors’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$285K Buy
2,759
+18
+0.7% +$1.61K 0.01% 303
2026
Q1 		$197K Sell
2,741
-592
-18% -$45.6K 0.01% 330
2025
Q4 		$265K Sell
3,333
-186
-5% -$14.7K 0.01% 294
2025
Q3 		$265K Sell
3,519
-1,465
-29% -$100K 0.02% 294
2025
Q2 		$344K Sell
4,984
-538
-10% -$35.3K 0.02% 243
2025
Q1 		$374K Buy
5,522
+1,665
+43% +$99.6K 0.03% 229
2024
Q4 		$173K Sell
3,857
-304
-7% -$17.1K 0.01% 305
2024
Q3 		$262K Sell
4,161
-248
-6% -$14.5K 0.02% 260
2024
Q2 		$260K Sell
4,409
-342
-7% -$21.4K 0.02% 213
2024
Q1 		$379K Sell
4,751
-1,130
-19% -$86.3K 0.03% 177
2023
Q4 		$464K Sell
5,881
-393
-6% -$28K 0.04% 151
2023
Q3 		$438K Buy
6,274
+609
+11% +$43.2K 0.04% 157
2023
Q2 		$392K Sell
5,665
-639
-10% -$45.5K 0.04% 163
2023
Q1 		$468K Sell
6,304
-756
-11% -$63.4K 0.04% 150
2022
Q4 		$658K Sell
7,060
-191
-3% -$18.4K 0.06% 137
2022
Q3 		$692K Sell
7,251
-108
-1% -$10.7K 0.08% 126
2022
Q2 		$682K Buy
7,359
+661
+10% +$64.5K 0.07% 125
2022
Q1 		$678K Sell
6,698
-54
-0.8% -$5.67K 0.06% 140
2021
Q4 		$697K Sell
6,752
-512
-7% -$47.3K 0.07% 136
2021
Q3 		$616K Buy
7,264
+794
+12% +$66.5K 0.06% 139
2021
Q2 		$540K Sell
6,470
-191
-3% -$15.6K 0.08% 113
2021
Q1 		$501K Sell
6,661
-89
-1% -$6.48K 0.1% 101
2020
Q4 		$461K Buy
6,750
+100
+2% +$6.5K 0.1% 99
2020
Q3 		$388K Buy
6,650
+1,436
+28% +$89.4K 0.09% 101
2020
Q2 		$339K Hold
5,214
– – 0.09% 104
2020
Q1 		$309K Sell
5,214
-8,855
-63% -$591K 0.09% 99
2019
Q4 		$1.04M Sell
14,069
-602
-4% -$42.3K 0.26% 73
2019
Q3 		$925K Sell
14,671
-1,800
-11% -$107K 0.24% 76
2019
Q2 		$898K Buy
16,471
+6,044
+58% +$325K 0.23% 77
2019
Q1 		$562K Buy
10,427
+240
+2% +$14.8K 0.15% 86
2018
Q4 		$667K Sell
10,187
-1,222
-11% -$91.2K 0.18% 80
2018
Q3 		$898K Sell
11,409
-2,646
-19% -$189K 0.23% 68
2018
Q2 		$904K Sell
14,055
-1,058
-7% -$69.7K 0.24% 66
2018
Q1 		$940K Sell
15,113
-812
-5% -$58.3K 0.25% 64
2017
Q4 		$1.16M Sell
15,925
-80
-0.5% -$5.82K 0.28% 61
2017
Q3 		$1.3M Sell
16,005
-2,107
-12% -$167K 0.34% 58
2017
Q2 		$1.46M Sell
18,112
-1,580
-8% -$125K 0.4% 55
2017
Q1 		$1.55M Hold
19,692
– – 0.42% 57
2016
Q4 		$1.55M Sell
19,692
-3,241
-14% -$262K 0.42% 57
2016
Q3 		$2.04M Buy
22,933
+3,835
+20% +$362K 0.58% 42
2016
Q2 		$1.83M Buy
19,098
+1,314
+7% +$131K 0.51% 52
2016
Q1 		$1.84M Sell
17,784
-715
-4% -$69.5K 0.54% 39
2015
Q4 		$1.81M Buy
18,499
+1,144
+7% +$112K 0.52% 38
2015
Q3 		$1.67M Buy
17,355
+16,251
+1,472% +$1.71M 0.74% 32
2015
Q2 		$116K Sell
1,104
-6
-0.5% -$613 0.06% 118
2015
Q1 		$115K Hold
1,110
– – 0.05% 122
2014
Q4 		$107K Sell
1,110
-41
-4% -$3.61K 0.02% 125
2014
Q3 		$92K Buy
1,151
+2
+0.2% +$158 0.02% 132
2014
Q2 		$87K Buy
+1,149
New +$86.8K 0.02% 138
2014
Q1 		– Sell
-3,441
Closed -$246K – 118
2013
Q4 		$246K Sell
3,441
-393
-10% -$25.3K 0.11% 110
2013
Q3 		$218K Buy
+3,834
New +$228K 0.1% 115

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

JFS Wealth Advisors's CVS Position: Q2 2026 in Review

JFS Wealth Advisors increased its CVS Health (CVS) stake by 0.66% in Q2 2026, buying an estimated $1.61K and bringing the position to 2,759 shares worth $285K. The position accounts for 0.01% of the portfolio, ranked #303.

JFS Wealth Advisors first reported a position in CVS in Q3 2013 and has held it in 51 quarters since. The position peaked at $2.04M in Q3 2016. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.

  • JFS Wealth Advisors held 2,759 shares of CVS Health worth $285K as of Q2 2026.
  • JFS Wealth Advisors bought 18 CVS Health shares in Q2 2026, an estimated $1.61K.
  • CVS Health made up 0.01% of JFS Wealth Advisors's portfolio in Q2 2026, its #303 holding.
  • JFS Wealth Advisors first reported a position in CVS Health in Q3 2013 and has held it in 51 quarters since.
  • JFS Wealth Advisors's CVS Health position peaked at $2.04M in Q3 2016.
  • 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.

Based on JFS Wealth Advisors's 13F filing for Q2 2026, filed 10 Jul 2026.